Axolabs has been at the centre of RNA drug development for over 20 years, trusted by more than 250 biotech firms and major pharmaceutical partners. Their scientific capability is world-class — but their digital presence did not reflect it. Investors and partners could not see the scale of the opportunity at a glance.
“World-class scientific capability — a digital presence to match”
We developed a digital platform that presents Axolabs' leadership in RNA therapeutics clearly and confidently — designed to serve both investors evaluating the opportunity and partners assessing capability.
Brand identity by Craig Ward & Ward.Studio.
Craig Ward and Ward.Studio created a striking brand identity for Axolabs that captures the precision and innovation of RNA therapeutics. The logo, colour palette, and visual language they developed gave us a strong foundation to build the digital platform on.
Using Ward.Studio's brand as the foundation, we designed and built the Axolabs digital platform — translating the visual identity into a structured, functional investor and partner-facing website that communicates the science, the commercial opportunity, and the team behind it.
